220 related articles for article (PubMed ID: 31455429)
1. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.
Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
[TBL] [Abstract][Full Text] [Related]
2. Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cells.
Ichiki Y; Shigematsu Y; Baba T; Shiota H; Fukuyama T; Nagata Y; So T; Yasuda M; Takenoyama M; Yasumoto K
Cancer Sci; 2020 Nov; 111(11):4021-4030. PubMed ID: 32780528
[TBL] [Abstract][Full Text] [Related]
3. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
Li Q; Hu W; Liao B; Song C; Li L
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
[TBL] [Abstract][Full Text] [Related]
4. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG mice.
Zhang Q; Wang H; Li H; Xu J; Tian K; Yang J; Lu Z; Zheng J
Oncotarget; 2017 Feb; 8(6):9488-9499. PubMed ID: 28055955
[TBL] [Abstract][Full Text] [Related]
6. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
[TBL] [Abstract][Full Text] [Related]
7. Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition.
Otsuka T; Fukuyama T; Futawatari N; Tahara K; Watanabe M; Ichiki Y; Soeno T; Takahashi Y; Yamazaki H; Fujimori Y; Ohshiro T; Kobayashi N; Kida M; Koizumi W; Kusano C
J Cancer; 2022; 13(14):3526-3532. PubMed ID: 36484013
[No Abstract] [Full Text] [Related]
8. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.
Shirakura Y; Mizuno Y; Wang L; Imai N; Amaike C; Sato E; Ito M; Nukaya I; Mineno J; Takesako K; Ikeda H; Shiku H
Cancer Sci; 2012 Jan; 103(1):17-25. PubMed ID: 21951605
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
Fukuyama T; Hanagiri T; Takenoyama M; Ichiki Y; Mizukami M; So T; Sugaya M; So T; Sugio K; Yasumoto K
Cancer Res; 2006 May; 66(9):4922-8. PubMed ID: 16651449
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
11. A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
Chinnasamy N; Wargo JA; Yu Z; Rao M; Frankel TL; Riley JP; Hong JJ; Parkhurst MR; Feldman SA; Schrump DS; Restifo NP; Robbins PF; Rosenberg SA; Morgan RA
J Immunol; 2011 Jan; 186(2):685-96. PubMed ID: 21149604
[TBL] [Abstract][Full Text] [Related]
12. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.
Sun Q; Zhang X; Wang L; Gao X; Xiong Y; Liu L; Wei F; Yang L; Ren X
Cell Death Dis; 2019 Jun; 10(7):475. PubMed ID: 31209257
[TBL] [Abstract][Full Text] [Related]
13. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.
Shida A; Fukuyama T; Futawatari N; Ohmiya H; Ichiki Y; Yamashita T; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M; Takahashi Y
World J Gastroenterol; 2020 Jan; 26(4):424-432. PubMed ID: 32063691
[TBL] [Abstract][Full Text] [Related]
14. Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer.
Takahashi Y; Fukuyama T; Futawatari N; Ichiki Y; Ohmiya H; Chuman M; Yamashita T; Hiki N; Kumamoto Y; Yamazaki H; Nonoguchi H; Nishi Y; Kobayashi N
Anticancer Res; 2019 Nov; 39(11):6259-6263. PubMed ID: 31704855
[TBL] [Abstract][Full Text] [Related]
15. Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.
McCormack E; Adams KJ; Hassan NJ; Kotian A; Lissin NM; Sami M; Mujić M; Osdal T; Gjertsen BT; Baker D; Powlesland AS; Aleksic M; Vuidepot A; Morteau O; Sutton DH; June CH; Kalos M; Ashfield R; Jakobsen BK
Cancer Immunol Immunother; 2013 Apr; 62(4):773-85. PubMed ID: 23263452
[TBL] [Abstract][Full Text] [Related]
16. A rare population of tumor antigen-specific CD4
Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
Hsu R; Baca Y; Xiu J; Wang R; Bodor JN; Kim C; Khan H; Mamdani H; Nagasaka M; Puri S; Liu SV; Korn WM; Nieva JJ
Oncotarget; 2021 Dec; 12(25):2449-2458. PubMed ID: 34917263
[TBL] [Abstract][Full Text] [Related]
18. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer.
Chen X; Liu F; Yu X; Li L; Yan J; Chen X; Liu Q; Liu B
Eur J Med Chem; 2022 Nov; 241():114617. PubMed ID: 35932567
[TBL] [Abstract][Full Text] [Related]
19. Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Dillard P; Köksal H; Maggadottir SM; Winge-Main A; Pollmann S; Menard M; Myhre MR; Mælandsmo GM; Flørenes VA; Gaudernack G; Kvalheim G; Wälchli S; Inderberg EM
Mol Ther; 2021 Mar; 29(3):1199-1213. PubMed ID: 33212301
[TBL] [Abstract][Full Text] [Related]
20. T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor.
Lee YS; Kim TS; Kim DK
BMC Cancer; 2011 Jun; 11():225. PubMed ID: 21649881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
